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Adequate staging and treatment of the neck in squamous cell carcinoma of the oral cavity and oropharynx (OSCC) is of
paramount importance. Elective neck dissection (END) of the clinical N0-neck is widely advocated as neck treatment. With
regard to the prevalence of 20–40% of occult neck metastases found in the ND specimens, the majority of patients undergo
surgery of the lymphatic drainage basin without therapeutic benefit. Sentinel node biopsy (SNB) has been shown to be a safe,
reliable and accurate alternative treatment modality for selected patients. Using this technique, lymphatic mapping is crucial.
Previous reports suggested a benefit of single photon emission computed tomography with CT (SPECT/CT) over dynamic planar
lymphoscintigraphy (LS) alone. SPECT/CT allows the surgeon for better topographical orientation and delineation of sentinel
lymph nodes (SLN’s) against surrounding structures. Additionally, SPECT/CT has the potential to detect more SLN’s which might
harbour occult disease, than LS. SPECT/CT is recommended to be used routinely, although SPECT/CT is not indispensable for
successful SNB.
1. Background
Squamous cell carcinoma of the oral cavity and oropharynx
(OSCC) accounts for one of the most common cancers
worldwide, with more than a quarter million new cases
annually [1]. The presence or absence of lymph node involve-
ment is of paramount importance for prognosis and therapy
decision [2, 3]. Therefore, an adequate staging and man-
agement of the neck is needed. The most challenging issue
remains the treatment of the clinically and radiologically
negative neck. Most centers throughout the world advocate
elective neck dissection (END) for histopathologic staging
and removal of microscopic disease in this situation. With
regard to the prevalence of 20%–40% of occult neck metas-
tases found in the neck dissection specimens, the majority
of patients undergo surgery of the lymphatic drainage basin
without therapeutic benefit. Sentinel node biopsy (SNB)
has been shown to be very accurate in selecting patients
who benefit from elective neck treatment and sparing the
costs and morbidity to the others. Detection of the sentinel
nodes by lymphatic mapping is crucial with this technique.
Single-photon emission computed tomography with CT
(SPECT/CT) has been recently introduced to enhance the
diagnostic accuracy of preoperative lymphoscintigraphy.
2. Sentinel Node Biopsy
By definition, the sentinel lymph node (SLN) is the first
draining lymph node to receive lymphatic drainage from a
primary tumor of a specific site [4]. In case of lymphatic
spread, the lymphatic drain will first pass the SLN. All follow-
ing nodes may be reached only subsequently by the disease.
Therefore, selective excision of the SLN with subsequent
thorough histopathologic work-up reflects adequately the
nodal status of the remaining neck [5]. Since Alex and Krag
[6] have described their first experience with SNB for OSCC,
the technique has gained large popularity and many centers
followed with validation and observational studies [7–9].
Lymphatic mapping of the SLN in the complex head and
neck area has been shown to be essential [10]. The problems
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in the head and neck area are threefold: first, there is a
high density of lymph nodes, second, the structure of these
nodes shows an unique complexity of lymphatic pathways,
and third, the SLNs are located in close proximity to the
primary tumor. Therefore, sophisticated lymphatic mapping
techniques are required. During the preoperative setting,
a dynamic lymphoscintigraphy (LS) assesses the individual
draining pattern after injection of radiolabeled particles
around the primary tumor. The intraoperative use of a hand-
held gamma probe helps the surgeon to localise and excise
the first echelon lymph nodes. The success of this technique
has been abundantly reported in the literature and well-
documented guidelines do exist [11]. As with breast cancer,
preliminary reports showed a new imaging technology with
promising results: SPECT/CT.
3. Patient’s Selection
For SNB of the OSCC, patients with stages I and II (T1
and T2) disease and no clinical and radiological evidence
of cervical lymph node involvement are eligible. Absence of
suspicious or metastatic lymph nodes is based on palpation,
ultrasound with fine needle aspiration cytology (FNAC),
or contrast-enhanced computed tomography (CT), or mag-
netic resonance imaging (MRI), or 18F-fluoro-2-deoxy-D-
glucose positron emission tomography (18F-FDG-PET)/CT.
With regard to conventional imaging, lymph nodes greater
than 1.5 cm in level II and greater than 1 cm in all other levels,
or lymph nodes with round shape, central necrosis, and
peripheral contrast enhancement are considered pathologic.
In metabolic imaging, a lymph node with a clearly higher
FDG-uptake compared to the background and anatomically
corresponding to a lymph node in the low-dose CT scan is
considered pathologic.
4. Tracer
To assess the individual lymphatic drainage pattern, a peri-
tumoral injection of radiolabeled particles is performed. The
particles will enter the lymphatic capillaries and accumulate
in the first draining node. There is a variety of colloidal and
soluble tracers available although most trials report using
Tc-99m-labeled human serum albumin colloid (Nanocoll,
GE Healthcare). With its particle size of 8–30 nm, Nanocoll
migrates to the sentinel node within minutes and remains
there until the next day [11, 12]. This allows a flexible way
for planning surgery to take place.
5. Imaging
A standard technique for preoperative imaging is the use
of a gamma camera for lymphoscintigraphy to assess the
individual drainage pattern of the injected radiolabeled
tracer via the capillaries to the larger collector lymphatics
[13]. Imaging will be performed either the day before or the
day of surgery. According to the joint practice guidelines for
radionuclide lymphoscintigraphy, the setting of the camera
is proposed to be as follows. A large-field-of-view gamma
camera provided with a high- or ultrahigh-resolution low-
energy collimator should be used, with a 10%–20% window
centered on the 140-keV energy peak of Tc-99m [11]. The
gamma camera should be routinely checked for quality
control as proposed in published protocols [14].
Immediately after the injection of the radiotracer, the
lymphatic drainage is monitored dynamically with the
gamma camera in the anteroposterior projection (1 image/3
minutes). The lymphatic drainage is then observed by the
nuclear medicine specialist and the HN-surgeon at the
monitor. When accumulation of the radiotracer in the
first echelon node(s) occurs, the dynamic imaging can be
interrupted and static imaging in the anterior-posterior,
lateral and, if necessary, anterior oblique view can be
performed. For the different projections, a three-headed
camera is recommended. To be able to localize the nodes
in a three-dimensional view, static images in at least two
projections are needed. The patient is imaged in the supine
position with head up [11].
Most reports in the literature use the term sentinel
node interchangeably for lymphoscintigraphy and SNB.
As most tracer accumulations or hot spots detected by
lymphoscintigraphy or SPECT/CT correspond to more than
one ultimately excised sentinel lymph node, the term hot spot
should be used in the context of planar imaging or fused
imaging whereas sentinel lymph node should be used in the
context of surgical SNB.
Intraoperatively, the surgeon will be guided to the
sentinel nodes by a hand-held gamma probe containing a
radiation detector with surrounding metal shielding and a
collimated tip. The response related to the detected count
rate is provided by a connected analyzer [11].
Using this technique, SNB has become a safe and reliable
method to detect SLNs with a previously published SLN
detection rate of 96% [5].
6. SPECT/CT for Sentinel Node Mapping in
HNSCC: A Comparison in the Literature
Besides the previously described imaging technique using a
preoperative lymphoscintigraphy, novel systems composed
of a gamma camera and a CT scan combined in the
same device have been recently introduced into clinical
practice. Single photon emission CT (SPECT) and CT data
are acquired at the same clinical setting without changing
the patient’s positioning, thus allowing for generation of
accurate fused images combining the functional data of
SPECT with the anatomical data of the CT scan (Figure 1).
Different centers have already reported on their experience
with SPECT/CT for SLN mapping in early OSCC, however,
with contradictory results [11, 15–24]. In 2000, Even-Sapir
et al. described the fusion of the SPECT lymphoscintigraphy
data with CT using a hybrid gamma-camera and a low-
dose CT system that allows SPECT and CT to be performed
at the same time without changing the patient’s position
[25]. Three years later, the same author introduced the
hybrid SPECT/CT system into sentinel node mapping of
HNSCC [15]. In 2004, two feasibility studies using planar
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Figure 1: 64-year-old female suffering from a left-sided tongue cancer. (a) shows the MIP (maximum intensity projection)—image of
SPECT acquisition in anteroposterior view. A large uptake is seen at the injection site with a small, focal uptake of the left lower boarder
(cross hair). (b) shows a fused coronal SPECT/CT image that localises the small focal uptake in the neck region level IIA/B. (c) shows the
axial SPECT image with the corresponding cross hair in the sentinel node with a clear delineation from the injection site. (d) shows the
corresponding low-dose CT scan localising the uptake by linked cross hair into the neck level IIA/B.
lymphoscintigraphy and SPECT/CT were published [16, 17].
Lopez et al. included ten patients stating that they believe
that SPECT/CT will become a useful tool for sentinel node
mapping [16]. Wagner et al. found an additional value
by using SPECT/CT for sentinel node mapping than lym-
phoscintigraphy alone [17]: they have found an additional
lymph node nearby the submandibular gland which has
only been detected by SPECT/CT. This lymph node has
been overlooked by planar lymphoscintigraphy and the
intraoperative gamma probe as the radioactive scattering
from the primary obscured the location of the radiolabeled
SLNs. The same problem has been shown by other authors
in the earlier period of radioguided imaging [26, 27] and was
thought be resolved by introducing SPECT/CT. Thomsen
et al. found SLNs close to the primary difficult to detect.
Therefore, added oblique planar images and/or tomographic
scans would help to overcome this problem [18]. Terada et
al. also performed a feasible study on SPECT/CT and HN
mucosal carcinoma and concluded that they were able to
extract all the SLNs based on the fusioned images and to
confirm its radioactivity with the gamma probe without the
adverse effect of overlapping radioactivity from the primary
site [19]. Khafif et al. included 22 patients with biopsy proven
OSCC and found an improved identification of the SLNs of
30% compared to planar imaging [20]. Bilde et al. included
34 consecutive patients with stages I and II OSCC under-
going planar lymphoscintigraphy and SPECT/CT. After all,
SPECT/CT demonstrated an extra SLN in 47% compared
to lymphoscintigraphy alone [21]. In the same year, Keski-
Sa¨ntti et al. were the first and only authors who found
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Table 1: An overview of various studies using SPECT/CT in the context of lymphatic mapping for SNB in OSCC.
Study group
Number of
patients (n)
SPECT/CT and the reported detection of SLN’s
The value of SPECT/CT according to the
authors
Even-Sapir et al.
[15]
6
3 additional nodes detected in 6 patients
compared to lymphoscintigraphy alone
SPECT/CT adds data that is of clinical
relevance to SNB in patients with
mucosal HNSCC
Lopez et al. [16] 10 100% visualization of the SLN’s by SPECT/CT
SPECT/CT is shown to be an effective
method for anatomic localization of the
SLN’s in N0 OSCC
Wagner et al.
[17]
30
11 additional nodes out of 49 SLNs detected
compared to lymphoscintigraphy alone
SPECT/CT adds additional information
regarding nodes that are adjacent to the
primary lesion
Thomsen et al.
[18]
40
SPECT/CT and/or added oblique images
revealed extra nodes in 15/40 patients.
SPECT/CT has added information which
could not have been obtained from
planar lymphoscintigraphy
Terada et al.
[19]
15 100% visualization of the SLN’s by SPECT/CT
SPECT/CT proved to be an easy,
accurate, and reliable method
Khafif et al. [20] 20
SPECT/CT improved SLN identification
and/or localization compared with planar
images in 6 patients (30%)
SPECT/CT provides additional
preoperative data of clinical relevance to
SNB in patients with OSCC
Bilde et al. [21] 34
SPECT/CT demonstrated extra SLN’s
compared to planar imaging in 15 out of 32
patients (47%)
SPECT/CT detects more SLN’s than
lymphoscintigraphy and provides
additional anatomical and spatial
information about their localization.
Keski-Sa¨ntti et
al. [22]
15
1 additional SLN located in the jugular chain
detected compared to lymphoscintigraphy
alone
SPECT/CT enables more accurate
localization of the SLN’s, but it rarely
reveals SLN’s, that are not detected on
planar images.
Haerle et al. [23] 58
11 additional hot spots could be revealed by
SPECT/CT compared to lymphoscintigraphy
alone. In one case even with additional occult
disease.
SPECT/CT has the potential to detect
more SLN’s, which might harbour occult
disease, than lymphoscintigraphy alone.
SNB: sentinel node biopsy; OSCC: oral/oropharyngeal squamous cell carcinoma; HNSCC: head and neck squamous cell carcinoma; SLN: sentinel lymph node.
no additionally revealed SLNs by SPECT/CT compared
to planar imaging [22]. They concluded that despite the
better topographical orientation achieved by SPECT/CT, it is
not necessarily needed for preoperative lymphatic mapping.
The largest single institutional cohort study was done by
Haerle et al. A total of 58 patients undergoing SNB with
preoperative lymphoscintigraphy and SPECT/CT have been
described. Lymphoscintigraphy showed full concordance
with SPECT/CT in 81% of the cases. SPECT/CT was able
to detect additional HS in eleven patients, in one case even
with additional metastatic disease. Therefore, in conclusion,
SPECT/CT has the potential to detect more SLNs, which
might harbour occult disease, than Lymphoscintigraphy
alone. However, with regard to the excellent results achieved
with LS and the intraoperative use of the gamma probe,
SPECT/CT is not indispensable for successful SNB. The
additional hot spots have all been detected in the same levels
or in levels close to those in which lymphoscintigraphy has
already shown hot spots. Therefore, both imaging modalities
have difficulties in detecting level I sentinel nodes close to the
injection site [23]. In summary, the reported series looking
at preoperative sentinel node mapping for OSCC were all
smaller series apart from the latter series [23]. An overview
of the different series is shown in Table 1.
7. In the Future
Wherever applicable and affordable, SPECT/CT might
become a routine preoperative imaging solution in the
context of SNB for OSCC. As technical developments in
SPECT/CT are ongoing [28] and high-resolution multislice
CT scanners and the use of intravenous contrast will be
integrated in SPECT/CT systems, even further improved
spatial resolution of CT images and a better delineation of
tumor adjacent structures are available. Together with the
use of novel portable gamma-camera systems tested recently
[29], possibly the future will provide an integrated system
that combines fused imaging with an intraoperative hand-
held gamma-camera enabling three-dimensional visualiza-
tion [30]. Apart from imaging development, new tracers may
be integrated in the process of more accurate detection of the
sentinel lymph nodes.
8. Conclusions
The technique of SNB offers a reliable, safe, and individual
treatment plan for each patient’s unique lymphatic drainage
pattern causing low morbidity. The use of this successful
technique allows the surgeon to select patients for elective
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neck dissection of the N0-neck. The use of preoperative
planar lymphoscintigraphy and an intraoperative hand-held
gamma probe results in excellent sentinel node-detection
rates. SPECT/CT allows the surgeon for better topographical
orientation and delineation of SLNs against surrounding
structures, for example, muscles, vessels, and bones. Addi-
tionally, the surgical time may be reduced with regard to
better spatial resolution. SPECT/CT has the potential to
detect more SLNs, which might harbour occult disease,
than lymphoscintigraphy alone. Therefore, we recommend
using SPECT/CT routinely, although SPECT/CT is not
indispensable for successful SNB.
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